NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Therapies



Tamoxifen Not Harmful to Endothelial Function



May 6th, 2000

Scientists say that despite tamoxifen's estrogen agonist and antagonist characteristics, the drug is not harmful to endothelial function in postmenopausal breast cancer patients.

To assess the potentially negative effect of tamoxifen on the cardiovascular system, Paul J.L. Ong and colleagues designed a study of 22 postmenopausal women with breast cancer. The women fell into one of three groups:

  • Group 1: Recently diagnosed breast cancer patients

  • Group 2: Patients who had been receiving long-term tamoxifen

  • Group 3: Breast cancer patients in remission who did not take tamoxifen

    Ong et al. assessed Group 1 both...


    Source: Women's Health Weekly (2000-05-06)

  • NewsRx Passes
    Advertisement
    More Articles

    ------------------------
    Security by Verisign PR Login